Published in Science on October 08, 2010
Direct-to-consumer personalized genomic testing. Hum Mol Genet (2011) 1.61
Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med (2012) 1.17
Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers. Genome Med (2014) 1.14
Pharmacogenetics in psychiatry: translating research into clinical practice. Mol Psychiatry (2011) 1.13
A randomized trial of genetic information for personalized nutrition. Genes Nutr (2012) 1.08
Increasing Public Awareness of Direct-to-Consumer Genetic Tests: Health Care Access, Internet Use, and Population Density Correlates. J Cancer Epidemiol (2012) 0.98
Update on Direct-to-Consumer Marketing in Oncology. J Oncol Pract (2012) 0.97
Direct-to-consumer testing: if consumers are not anxious, why are policymakers? Hum Genet (2011) 0.91
Health system implications of direct-to-consumer personal genome testing. Public Health Genomics (2010) 0.90
Field of genes: an investigation of sports-related genetic testing. J Pers Med (2012) 0.86
Characteristics of genomic test consumers who spontaneously share results with their health care provider. Health Commun (2013) 0.85
The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations. Clin Genet (2011) 0.83
Health care providers and direct-to-consumer access and advertising of genetic testing in the United States. Genome Med (2011) 0.78
Regulating genetic tests: account for benefits. Science (2010) 0.78
Regulating genetic tests: who owns the data? Science (2010) 0.78
International network of cancer genome projects. Nature (2010) 20.35
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA (2008) 5.25
Stem cell tourism and doctors' duties to minors--a view from Canada. Am J Bioeth (2010) 4.93
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
Offering individual genetic research results: context matters. Sci Transl Med (2010) 4.51
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet (2013) 4.06
Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet (2008) 4.03
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med (2012) 3.44
Medicine. The future of personal genomics. Science (2007) 3.36
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. JAMA (2006) 3.20
ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol (2007) 3.19
Point-counterpoint. Ethics and genomic incidental findings. Science (2013) 2.73
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell (2008) 2.35
Genomics. Deflating the genomic bubble. Science (2011) 2.20
Pharmacogenetic testing: not as simple as it seems. Genet Med (2008) 2.18
Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet (2003) 2.11
Personal medicine--the new banking crisis. Nat Biotechnol (2012) 2.09
The FDA and genomic tests--getting regulation right. N Engl J Med (2015) 2.09
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med (2013) 2.08
Science communication reconsidered. Nat Biotechnol (2009) 2.02
Informed consent in genomics and genetic research. Annu Rev Genomics Hum Genet (2010) 1.98
Next-generation sequencing in the clinic: are we ready? Nat Rev Genet (2012) 1.95
Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience. Genome Res (2011) 1.91
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
Biobanks, consent and claims of consensus. Nat Methods (2012) 1.66
Researcher perspectives on disclosure of incidental findings in genetic research. J Empir Res Hum Res Ethics (2010) 1.55
To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med (2011) 1.52
Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med (2008) 1.51
Clinical decisions. Screening an asymptomatic person for genetic risk. N Engl J Med (2014) 1.51
Informed Consent in Genome-Scale Research: What Do Prospective Participants Think? AJOB Prim Res (2012) 1.50
Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet Med (2010) 1.47
Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer (2008) 1.45
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med (2011) 1.36
Taking family history seriously. Ann Intern Med (2005) 1.36
Diverse perceptions of the informed consent process: implications for the recruitment and participation of diverse communities in the National Children's Study. Am J Community Psychol (2012) 1.28
Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries. BMC Med Ethics (2010) 1.28
Trends in death associated with pediatric dental sedation and general anesthesia. Paediatr Anaesth (2013) 1.28
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications? Genet Med (2005) 1.27
Stem cell clinics in the news. Nat Biotechnol (2010) 1.22
Ethical issues in identifying and recruiting participants for familial genetic research. Am J Med Genet A (2004) 1.20
Offering aggregate results to participants in genomic research: opportunities and challenges. Genet Med (2012) 1.19
An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med (2003) 1.18
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genet Med (2013) 1.16
Return of results: ethical and legal distinctions between research and clinical care. Am J Med Genet C Semin Med Genet (2014) 1.16
NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer. NIH Consens State Sci Statements (2013) 1.14
Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism. Transplantation (2010) 1.13
iPS cells: mapping the policy issues. Cell (2009) 1.11
Managing incidental genomic findings: legal obligations of clinicians. Genet Med (2013) 1.11
Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes. Genet Med (2007) 1.11
Educational needs in genetic medicine: primary care perspectives. Community Genet (2008) 1.09
Gene banks and blanket consent. Nat Rev Genet (2002) 1.08
Waiving informed consent in newborn screening research: balancing social value and respect. Am J Med Genet C Semin Med Genet (2008) 1.08
Cancer patient perceptions on the ethical and legal issues related to biobanking. BMC Med Genomics (2013) 1.08
Breast cancer risk counseling improves women's functioning. Patient Educ Couns (2004) 1.06
Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med (2007) 1.06
Anticipating dissemination of cancer genomics in public health: a theoretical approach to psychosocial and behavioral challenges. Ann Behav Med (2007) 1.05
Genetics researchers' and IRB professionals' attitudes toward genetic research review: a comparative analysis. Genet Med (2012) 1.05
Role and reality: technology transfer at Canadian universities. Trends Biotechnol (2010) 1.04
Does genomic risk information motivate people to change their behavior? Genome Med (2009) 1.03
Genome Medicine: past, present and future. Genome Med (2011) 1.03
Position statement on the provision and procurement of human eggs for stem cell research. Cell Stem Cell (2013) 1.02
Type 2 diabetes mellitus: issues for the medical care of pediatric and adult patients. South Med J (2002) 1.02
Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? Regen Med (2013) 1.00
Canadian newspaper coverage of the A/H1N1 vaccine program. Can J Public Health (2011) 1.00
Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers. BMC Med Ethics (2009) 0.99
Commercialization, patenting and genomics: researcher perspectives. Genome Med (2009) 0.99
Stakeholder perspectives on a risk-benefit framework for genetic testing. Public Health Genomics (2010) 0.98
Restricting marketing to children: consensus on policy interventions to address obesity. J Public Health Policy (2013) 0.98
Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials (2011) 0.98
Primary-care physicians' access to genetic specialists: an impediment to the routine use of genomic medicine? Genet Med (2013) 0.97
Genetic exceptionalism. Too much of a good thing? Genet Med (2008) 0.97
From leaky pipeline to irrigation system: minority education through the lens of community-based participatory research. Prog Community Health Partnersh (2012) 0.97
Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev (2005) 0.97
Genetic information: Special or not? Responses from focus groups with members of a health maintenance organization. Am J Med Genet A (2007) 0.96
Implementation outcomes of a multiinstitutional web-based ethical, legal, and social implications genetics curriculum for primary care residents in three specialties. Genet Med (2011) 0.96
Newspaper reporting on legislative and policy interventions to address obesity: United States, Canada, and the United Kingdom. J Public Health Policy (2010) 0.96
Effects of individual and family functioning on interest in genetic testing. Community Genet (2004) 0.94
Effects of web-based intervention on risk reduction behaviors in melanoma survivors. J Cancer Surviv (2014) 0.94
The rules remain the same for genomic medicine: the case against "reverse genetic exceptionalism". Genet Med (2010) 0.93
Beneficence, clinical urgency, and the return of individual research results to relatives. Am J Bioeth (2012) 0.93
Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people. Am J Public Health (2013) 0.91
Cytochrome p450 enzyme polymorphism frequency in indigenous and native american populations: a systematic review. Community Genet (2008) 0.91
Population description and its role in the interpretation of genetic association. Hum Genet (2010) 0.90
Health system implications of direct-to-consumer personal genome testing. Public Health Genomics (2010) 0.90